Jobs / United States / Astrazeneca Pharmaceuticals Lp
Medical Director, Early Clinical Development, Oncology
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Do you have expertise in, and passion for early stage clinical development? Are you looking to work at the cutting-edge, where scientific innovations and an entrepreneurial spirit are the norm? Join the team at the heart of AstraZeneca that is committed and encouraged to follow the science in Oncology R&D. About AstraZeneca AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines for some of the world’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies. We have a bold ambition to provide cures for cancer in every form. We are following the science to understand cancer and all its complexities to discover, develop and deliver life-changing treatments and increase the potential to save the lives of people around the world. One area of significant investment is to build internal infrastructure to be a leader in next generation of products in Oncology. Using historical expertise in biologics engineering, gene editing and immune expertise across solid and hematological malignancies, AstraZeneca is uniquely positioned to develop the best technologies and is already growing a differentiated pipeline. About Early Clinical Development Medical Directors Our Medical Directors, at all levels, possess a clinical background and are driven by science and the desire to develop novel therapies for cancer patients to work in our dynamic Early Clinical Development team. You will have a proficiency in the drug development process, particularly early phase clinical trials, protocol writing and study conduct, data review and reconciliation, and what it takes to lead teams successfully. This position offers the opportunity for growth and development while working in a vibrant environment. AstraZeneca is in a period of tremendous growth and acceleration in the oncology portfolio. This is a fast-paced and dynamic work environment where, with growing levels of responsibility. Typical responsibilities may include: • Provide long-range clinical planning in early clinical trial development, planning and managing of clinical research projects and clinical development programs in oncology. • Serve as the Project Medical Monitor while working in a cross functional environment with representatives from other involved line functions as well as Late-Stage Development. • Contribute to and support Department/Clinical initiatives to improve the quality and content of all clinical programs as well as the cross functional/organization processes designed to effectively deliver our R&D portfolio. • Establish and approve scientific methods for design and implementation of applicable clinical protocols, data collection systems, and final reports; • Play a role in designing clinical development plans and overall strategy for compounds, therapeutic classes of compounds or indications in light of developments in the area of clinical and pharmaceutical oncology; • Participate in identification, selection and conduct of negotiations with clinical research centers and investigators; • Participate in the selection and management activities of CROs; Supervise project team members in planning, conducting and evaluating clinical trials; • Lead all aspects of planning and management of investigator meetings, advisory boards and other scientific committees. Essential Requirements: • M.D degree or equivalent. Strong preference for individuals with clinical training in oncology or hemato-oncology • At least 3 years of experience in clinical research and/or oncology drug development in pharmaceutical, academic or CRO environment. Preferred Requirements: • PhD in a relevant research area is pref